• Feather Safety Razor
  • MWE Medical Wire
  • We make diagnostics that matter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe, it’s free!
  • Search
  • Menu Menu
Clinical Laboratory int.

Archive for category: E-News

E-News

Beckman Coulter partners with Smart4Diagnostics to reduce preanalytical errors between blood collection and lab analysis

, 22 June 2022/in E-News /by panglobal

Beckman Coulter partners with Smart4Diagnostics

Beckman Coulter has formed a partnership with Germany-based Smart4Diagnostics in an effort to close the preanalytical data gap between blood collection and laboratory analysis due to errors that take place before the sample arrives in the laboratory. These can be errors in sample collection, patient identification, sample handling, sample transportation and sample loss, for example.

According to Dr Hans Maria Heyn, CEO & co-founder of Smart4Diagnostics: “As many as three in four medical decisions are based on diagnostic results – often blood samples. Currently, the first part of this process is being managed manually, which can lead to errors and cause issues, including slow diagnosis, repeated tests on the patient, and wasted resources. This partnership with Beckman Coulter seeks to revolutionise this crucial but underdeveloped area of the healthcare value chain to bring innovation where it can have an instant and substantial impact.”

Smart4Diagnostics has created a data-driven preanalytical ecosystem. From sample ordering to sample arrival, the company collects all relevant data-points to completely monitor sample workflow and conditions. By doing so, it is able to reduce preanalytical errors while also improving the preanalytical workflow and quality of treatment.

Clinical laboratories are well aware of the problems encountered in the preanalytical phase of the sample journey, which is when the vast majority of errors take place. Up to 75% of the errors in the preanalytical phase take place outside of the lab, meaning that laboratories have very little, if any, control over this part of the process. In European and North American hospitals, a single pre-analytical error costs on average €200, with the estimated costs of such errors totalling approximately 0.7% of all operating costs.

“Beckman Coulter has been automating and digitising medical laboratories throughout the world for over 40 years, and has now turned its attention to digitising the part of the preanalytical phase that happens outside of the laboratory. Thanks to the partnership with Smart4Diagnostics, Beckman Coulter will be able to monitor not only what happens inside the laboratory but the entire sample process, filling the existing gap between sample collection and clinical laboratories,” said Tom Coulson, EU Senior Manager for Workflow & IT Solutions.

https://clinlabint.com/wp-content/uploads/sites/2/2022/06/Beckman_Coulter-S4DX.png 1080 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-22 07:56:202022-06-22 07:56:20Beckman Coulter partners with Smart4Diagnostics to reduce preanalytical errors between blood collection and lab analysis

World-first: A biomarker that can diagnose Parkinson’s disease

, 9 June 2022/in E-News /by panglobal

Researchers at Kobe University and Hiroshima University have successfully developed a bio- marker that will enable Parkinson’s disease to be rapidly and inexpensively diagnosed from blood serum samples.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/parkinsons-p450.png 720 960 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 12:06:432022-06-09 12:06:43World-first: A biomarker that can diagnose Parkinson’s disease

AffyXell expands its strategic partnership with GenScript ProBio

, 9 June 2022/in E-News /by panglobal

Avacta Group, a clinical stage oncology drug company developing innovative cancer therapies and diagnostics based on its proprietary pre|CISION and Affimer platforms, announced that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading biopharmaceutical manufacturer.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/avacta_logo.png 746 1967 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 11:57:282022-06-09 11:57:28AffyXell expands its strategic partnership with GenScript ProBio

New triterpene discovery overturns current knowledge of highly useful compound, opening up new world for drug discovery

, 9 June 2022/in E-News /by panglobal

A remarkable discovery and collaborative effort have revealed a new type of triterpenes, a group of organic compounds which are an important source of many medicines. Until now, all triterpenes were believed to be derived from squalene, itself a type of triterpene. However, for the first time, researchers witnessed biosynthesis, the formation of complex compounds […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/triterpenes.png 457 1022 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 09:14:002022-06-09 09:14:21New triterpene discovery overturns current knowledge of highly useful compound, opening up new world for drug discovery

CYTENA and ExcellGene to develop automated workflows for biotherapeutics cell line development

, 9 June 2022/in E-News /by panglobal

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics Contract Development & Manufacturing Organization (CDMO) that manufactures recombinant proteins. Together, the companies will streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/Cytena_logo.png 500 770 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 08:46:232022-06-09 08:46:23CYTENA and ExcellGene to develop automated workflows for biotherapeutics cell line development

Xyall secures €6 million Series B financing to spearhead commercialization of its automated tissue dissector

, 9 June 2022/in E-News /by panglobal

Xyall, a global innovator in molecular pathology, has attracted a Series B investment of €6 million to accelerate commercialization of its Tissector High Throughput and Tissector Table Top systems. 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/xyall-tissue-disector.jpg 788 1184 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 08:43:482022-06-09 08:43:48Xyall secures €6 million Series B financing to spearhead commercialization of its automated tissue dissector

KNAUER wins German Innovation Award 2022

, 9 June 2022/in E-News /by panglobal

KNAUER Wissenschaftliche Geräte, a developer of laboratory instruments and known for their liquid chromatography systems and components, was honoured with the German Innovation Award 2022 in Munich in April for their design and manufacture of large-scale plants, at its own risk, for the ncapsulation of mRNA for COVID-19 vaccines. Equipment for the production of millions of mRNA vaccine doses had […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/KNAUER_award-scaled.jpg 1704 2560 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 07:58:292022-06-09 07:58:29KNAUER wins German Innovation Award 2022

Greiner Bio-One appoints new head of business for Preanalytics

, 9 June 2022/in E-News /by panglobal

Dr Stefan Gebauer has taken over management of the “Preanalytics” product division at Greiner Bio-One in Kremsmünster, Austria. He has many years of professional and management experience in the healthcare industry, focussing primarily on medical products in the IVD sector. Before joining Greiner Bio-One, he successfully managed the “Therapy Management” product line at Bosch Healthcare […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/Stefan_Gebauer-scaled.jpg 2560 1707 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 07:56:142022-06-09 07:56:14Greiner Bio-One appoints new head of business for Preanalytics

Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer

, 9 June 2022/in E-News /by panglobal

Agilent Technologies says its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA (pembrolizumab) may be appropriate. 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/agilent-technologies-logo.png 798 1978 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 07:53:582022-06-09 07:53:58Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer

Aptamer Group and PinotBio extend collaboration for the development of Optimer-drug conjugates

, 9 June 2022/in E-News /by panglobal

Aptamer Group, the developer of novel Optimer binders to enable innovation in the life sciences industry, has extended its collaboration agreement with PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, to develop four new Optimer-drug conjugates for use as precision chemotherapeutics. 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/06/aptamer.png 786 964 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-06-09 07:24:062022-06-09 07:28:08Aptamer Group and PinotBio extend collaboration for the development of Optimer-drug conjugates
Page 1 of 174123›»
Click here for more information!

Latest issue of Clinical laboratory

June 2022

22 June 2022

Beckman Coulter partners with Smart4Diagnostics to reduce preanalytical errors between blood collection and lab analysis

20 June 2022

Werfen

20 June 2022

Werfen

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release

Parklaan 54a
5613 BH
Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only